During a system upgrade from Friday, Dec. 5, through Sunday, Dec. 7, the AAFP website, on-demand courses and CME purchases will be unavailable.
The role of collaborative care in improving outcomes in CRM
Provided by AAFP partner
Learn how collaborative care can help improve the outcomes for patients with cardio-renal-metabolic (CRM) disorders, including chronic kidney disease (CKD), cardiovascular disease (CVD), and type 2 diabetes (T2D).
A team-based approach may improve patient care for individuals with one or more CRM disorders. This may include comorbidity identification, risk factor management, treatment selection, and clinical outcomes.
The importance of managing glycemia, blood pressure, and lipids, along with incorporating specific therapies with cardiovascular and kidney benefits as part of a comprehensive risk-reduction strategy in T2D
How leading clinical guidelines from the American Diabetes Association (ADA), Kidney Disease: Improving Global Outcomes (KDIGO), and the American Association of Clinical Endocrinology (AACE) all support lifestyle modifications, treatment goals, and screening recommendations for patients with T2D
Disclaimer:
The posting of information and content on this page should not be considered an AAFP endorsement or recommendation of the partner or sponsor organization’s products, services, policies or procedures. The information and opinions expressed are those of partners and paid sponsors and do not necessarily reflect the views of the AAFP. The AAFP is not responsible for the content of third-party websites linked from this page. Any links on this page to third-party websites where goods and services are advertised are not endorsements or recommendations by the AAFP of the third-party sites, goods or services.